indomethacin in AGS cells. These findings indicate that GADD45α up-regulation is a COXindependent mechanism that is required for induction of severe gastric mucosal apoptosis and injury by NSAIDs, likely via a capase 9-dependent pathway of programmed cell death.
1 gastric epithelial cells. Intraperitoneal administration of sulindac and indomethacin both resulted in up-regulation of GADD45α expression and induction of significant injury and apoptosis in gastric mucosa of wildtype mice. GADD45α -/-mice were markedly more resistant to both sulindac and indomethacin-induced gastric mucosal injury and apoptosis than wildtype mice. Sulindac sulfide and indomethacin treatments also concentration-dependently increased GADD45α expression and apoptosis in AGS and RGM-1 cells. Anti-sense suppression of GADD45α expression significantly reduced sulindac and indomethacin-induced activation of caspase 9 and apoptosis in AGS cells. Pretreatments with exogenous prostaglandins and siRNA suppression of COX-1 and -2 did not affect up-regulation of GADD45α by sulindac sulfide and indomethacin in AGS cells. These findings indicate that GADD45α up-regulation is a COXindependent mechanism that is required for induction of severe gastric mucosal apoptosis and injury by NSAIDs, likely via a capase 9-dependent pathway of programmed cell death. 5 mPGE-1 is expected to reduce inflammation, fever and pain while allowing continued biosynthesis of gastroprotective prostanoids.
Mounting evidence indicates that NSAIDs also exert COX/prostaglandin-independent effects, such as inhibition of EGF signaling, regulation of cell cycle proteins such as p21 and cyclins, inhibition of the MAP-kinase pathway (Ishikawa et al, 1998; Tegeder et al, 2001) , and increased ubiquitination of proteins such as HIF-1α and β-catenin in T cells for degradation by the ubiquitin-proteasome (Jones et al, 2002; Dihlman et al, 2003) . NSAIDs also directly activate pro-apoptotic factors such as caspases and Bax (Zhou et al, 2001) , and down-regulate levels of survivin, an anti-apoptosis protein, both in vivo in human and rat gastric mucosa and in vitro in rat gastric epithelial RGM-1 cells (Chiou et al, 2005) . Our recent studies showed that exogenous PGE2 treatments do not alter survivin levels in the rat gastric mucosa or gastric epithelial cells, suggesting that regulation of survivin by NSAIDs occurs through COX/prostaglandinindependent pathways (Chiou et al, 2005) . Further understanding of how non-selective NSAIDs affect genes involved in the regulation of apoptosis remains crucial for designing new therapeutic or preventive strategies against induction of gastric mucosal injury, and is also useful for evaluating the efficacy of new drugs being developed.
GADD45α is a stress signal response gene involved in regulation of DNA repair and apoptosis (Hollander et al, 1999; Hildesheim et al, 2002) . GADD45α null mice exhibit severe genomic instability characterized by aneuploidy, centrosome amplification, aberrant mitosis, and
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J P E T # 1 6 8 1 5 3 6 cytokinesis (Hollander et al, 1999) . More strikingly, mice lacking GADD45α are susceptible to carcinogenesis induced by ionizing radiation, UV irradiation, and dimethylbenzanthracene (Hollander et al, 2001) . In addition, GADD45α is important in cellular response to a variety of stress stimuli and genotoxic agents that are known to induce apoptosis, such as hypoxia, growth factor withdrawal, ionizing radiation, hydroxyurea, and methanesulfonate (Fornace et al, 1992) .
UV radiation-induced apoptosis is deficient in GADD45α null mice (Hollander et al, 1999) .
Rebamipide, a gastro-protective agent that inhibits indomethacin-induced apoptosis, also downregulates GADD45α expression (Naito et al, 2005) , suggesting that NSAIDs may activate GADD45α expression as a mechanism of gastric cell apoptosis and gastric damage. The role of GADD45α in NSAID-induced gastric mucosal injury and apoptosis has not been explored. In this study, we investigated: 1) Whether GADD45α expression is up-regulated by sulindac and indomethacin treatments both in vitro in human gastric AGS and normal rat gastric and in vivo in mouse gastric mucosa. 2) Whether anti-sense suppression of GADD45α expression in AGS cells confers resistance to NSAIDs-induced apoptosis, and whether GADD45α null mice are resistant to NSAID-induced gastric injury. 3) Whether exogenous PGE2 treatment and siRNA suppression of COX-1 and -2 could inhibit up-regulation of GADD45α by sulindac and indomethacin in AGS cells. 4) Whether NSAIDs induce growth inhibition and caspase 9 activation in gastric epithelial cells, and whether they are associated with GADD45α up-regulation.
This article has not been copyedited and formatted. The final version may differ from this version. Louis MO). The indomethacin concentration used has previously been utilized to effectively induce experimental gastric mucosal injury in rodents within a few hours. The sulindac concentration was chosen because the daily recommended dose in humans for sulindac is double that of indomethacin. Four, eight and twenty four hours after administration of drugs, the mice were euthanized with 200mg/kg Nembutal, and laparotomy was immediately performed to excise the stomachs. Gastric samples for biochemical studies were prepared by scraping the mucosa and freezing it immediately in liquid nitrogen. Gastric samples for immunohistochemical studies were frozen and sectioned.
Quantitation of macroscopic injury in gastric mucosa
The stomachs were opened along the greater curvature and photographed using a Canon Powershot A70 digital camera (Canon USA inc., One Canon Plaza Lake Success, NY). Sections from 5 different gastric mucosal erosions were analyzed per treatment condition. Five randomly selected intact gastric mucosal areas were similarly analyzed per treatment condition.
Quantitation of fold gastric mucosal caspase-3 activity was performed using gastric mucosal scrapings and the colorimetric CasPASE apoptosis assay kit ( Geno Technologies, inc, Maryland Heights, MO) following manufacturer's instructions and as previously described (Chiou et al, 2005) . Gastric mucosal scarpings from 6 mice were utilized per condition and treatment.
Cell lines and treatments
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Real-time RT-qPCR
Total RNA was isolated utilizing the RNeasy mini kit (Qiagen, Valencia, CA), according to the manufacturer's instructions. 0.3 μ g of total RNA from each sample was used in a random primed reverse transcription (RT) reaction utilizing the MMLV reverse transcriptase (Applied Biosystems, Foster City, CA) to synthesize first strand cDNA. Quantitation of mRNA expression (first strand cDNA) was performed by Realtime qPCR using custom made gene specific primers (Invitrogen, Carlsbad, CA). The Human Gadd45α primer sequences were previously described (Chiou and Hoa, 2009) . Survivin primers were also previously described (Chiou et al, 2003) . Realtime qPCR data was analyzed using a method described by M.W.
Pfaffl (Pfaffl, 2001) . This method accounts for variations in amplification efficiency in the following formula:
Western blot analysis
Cells were lysed with protein lysis buffer (20 mM Tris-HCl (pH 7.9), 1. 
12
(Universal Imaging Corp., Downingtown, PA). Protein signal densities were subtracted from background densities and normalized to the corresponding β -actin signal densities.
Anti-sense suppression of Gadd45α
Morpholino anti-sense oligonucleotides were designed to block expression of human Gadd45α mRNA (Gene Tools, Philomath, OR). The oligonucleotide sequence used was previously described (Chiou and Hoa, 2009 ). AGS cells were seeded in 6 well tissue culture
plates to obtain 70% confluence the next day. Endoporter transfection reagent (Gene Tools, Philomath, OR) was used alone (mock transfection), or to deliver either negative control (inverse sequence to the antisense) or the antisense oligonucleotide at 5μM concentration into cells. 48
hours later Western blot analysis was utilized to determine the extent of suppression of 
Statistical analysis
Student's two-tailed t test was used to compare data between two groups. One-way analysis of variance and Bonferroni's correction were used to compare data between three or more groups. P-value < 0.05 was considered statistically significant.
This article has not been copyedited and formatted. The final version may differ from this version. 14
Results

Gastric mucosal injury and apoptosis in NSAID treated WT versus GADD45α -/-mice
Vehicle only treatment resulted in low basal amounts of visible gastric mucosal injury in WT mice at all the time points examined ( Figure 1A ). Sulindac and indomethacin treatments caused severe visible gastric lesions in WT mice at all the time points examined, compared to vehicle only treatment ( Figure 1A ). The extent of gastric mucosal injury was similar at 4 and 8 hours,
and slightly less at 24 hours after NSAIDs were administered ( Figure 1A ). Vehicle only treatment also resulted in low basal amounts of visible gastric mucosal injury in GADD45α -/-mice at all the time points examined ( Figure 1B ). Compared to vehicle only treatment, treatment with sulindac did not cause significantly greater amounts of visible gastric mucosal injury at all the time points examined in GADD45α -/-mice ( Figure 1B ). Indomethacin treatment caused slightly greater amounts of visible gastric mucosal injury in GADD45α -/-mice but the increase was not statistically significant ( Figure 1B ).
Immunofluorescence staining of gastric mucosal sections showed that caspase-3 is expressed almost ubiquitously in both the WT and GADD45α -/-mouse gastric mucosa treated with vehicle only, sulindac or indomethacin (Figure 2 , upper panels). The white dotted lines demarcate the borders of gastric mucosal lesions found in sulindac and indomethacin treated mice ( Figure 2 , upper panels), and showed that caspase-3 is also detectable in areas surrounding the lesions. This result is consistent with others' findings that caspase-3 expression is widely detected in normal human gastric mucosa (Kania et al, 2003) , and enabled us to measure caspase-3 activity in the mouse gastric mucosa as a method to determine the extent of apoptosis induction by NSAIDs. Basal caspase-3 activity was detected in the gastric mucosa of vehicle Figure 6B and C, respectively). Significant apoptosis was also induced by all concentrations of sulindac sulfide and indomethacin in control oligo transfected cells, at levels comparable to or slightly lower than that of mock transfected cells ( Figure 6B and C, respectively). In contrast, cells transfected with anti-sense GADD45α oligos were resistant to sulindac sulfide and indomethacin-induced apoptosis. Only the high concentrations of these NSAIDs utilized were able to induce significant amounts of apoptosis, and the fold inductions were dramatically lower than that in mock and control oligo transfected cells ( Figure 6B and C).
We investigated whether antisense GADD45α suppression affects the caspase 9 pathway of apoptosis. Western blot analysis showed that low levels of procaspase 9 were expressed in the cells, and treatments with sulindac sulfide and indomethacin did not alter procaspase 9 levels compared to vehicle treatment ( Figure 7A ). Basal levels of active caspase 9 p10 subunit were This article has not been copyedited and formatted. The final version may differ from this version. 
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GADD45α expression by sulindac sulfide and indomethacin treatments did not occur through prostaglandin/COX-dependent pathways.
Compared to mock transfections with no siRNAs, transfections with control RNA did not affect the expression of COX-1, COX-2 or GADD45α, in AGS cells ( Figure 8C , left panels).
Transfections with siRNAs targetting COX-1 and COX-2 effectively reduced COX-1 and COX-2 expressions, respectively, to almost undetectable levels ( Figure 8C , left top and middle panels).
Co-transfection of COX-1 and COX-2 siRNA effectively reduced both COX-1 and -2 to undetectable levels, as visualized by using both COX-1 and COX-2 gene specific primers in the same PCR reaction ( Figure 8C , left bottom panel). Effective suppression of COX-1, COX-2 or both by their respective siRNAs did not affect GADD45α levels ( Figure 8C , left panels). As 23 regulation is not the sole mechanism responsible, since, in gastric mucosa of GADD45α -/-mice, treatments with sulindac and indomethacin could still induced caspase-3 activation to significantly higher levels than treatment with vehicle only, and a moderate amount of apoptotic cells in and around gastric mucosal erosions. These indicated that both sulindac and indomethacin treatments induced apoptosis pathways that did not require the presence of GADD45α gene expression.
In agreement with our previous experience that acute mucosal damage by NSAIDs is rapidly produced via systemic effects, in this study, sulindac and indomethacin treatments produced severe gastric mucosal damage in WT mice as early as 4 hours after intraperitoneal injection.
The extent of injury was sustained for at least 8 hours after NSAID administration. The decrease in gastric mucosal damage observed at 24 hours after NSAIDs were administered was likely due to healing of the gastric mucosa in the absence of repeat NSAID treatment after the initial injection. Sulindac and indomethacin treatments did not induce significant gastric mucosal damage at all time points up to 24 hours in GADD45α null mice, suggesting that inhibition of NSAID-induced gastric mucosal injury in GADD45α null mice was not due to a delay in injury induction. Further, the effective resistance of GADD45α null mice to NSAID-induced gastric mucosal damage suggested that deletion of GADD45α may also inhibit other non-apoptotic cell deaths that also contribute to gastric mucosal injuries, since our data showed that only about a third of gastric mucosal cells in and around NSAID-induced erosions were apoptotic cells.
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Results from our AGS studies were inconsistent with our in vivo data showing that indomethacin is a more potent drug than sulindac in up-regulation of GADD45α expression and induction of gastric mucosal injury and gastric cell apoptosis. These differences may be due in part to the fact that we utilized sulindac, a prodrug that requires further breakdown in vivo to produce active metabolites, in our animal studies, while we utilized sulidac sulfide, the active metabolite of sulindac, directly in our cell culture studies. After the breakdown of sulindac in vivo, the resulting concentration of the active sulfide metabolite may be greatly diminished relative to the concentration of sulindac we administered. Another explanation is that the gastric carcinoma and naproxen, resulting in cancer cell apoptosis and/or growth arrest (Zerbini et al., 2006) .
GADD45α up-regulation is also observed in adult primary sensory and motor neurons after peripheral axonal injury (Befort et al., 2003) , and GADD45α has been shown to participate in lipopolysaccharide and ventilater-induced inflammatory lung injury (Meyer et al., 2009 ).
NSAIDs are known to have anti-proliferative effects on a variety of cell types. GADD45α overexpression has been shown to lead to growth arrest (Hollander and Fornace, 2002) .
Therefore, the possibility arises that up-regulation of GADD45α expression may mediate
NSAID-induced growth inhibition of gastric epithelial cells. The relationship between
GADD45α up-regulation and growth inhibition of gastric epithelial cells by NSAIDs is unknown. This study showed that low concentrations of indomethacin, but not sulindac sulfide, that was insufficient to induce cell death had growth inhibitory effects on AGS and RGM-1 cells, but did not up-regulate GADD45α expression. This indicated that in the gastric epithelial cells we utilized, GADD45α is not involved in inhibition of cell proliferation in response to NSAID treatments.
Our current study provided evidence that GADD45α up-regulation by NSAIDs triggers a caspase 9-dependent pathway of apoptosis. Caspase 9 is the initiator caspase involved in the intrinsic or mitochondrial pathway of apoptosis (Li et al, 1997) . Once activated, it cleaves and activates downstream effector caspases such as caspase 3 and/or 7 to induce apoptosis (Taylor et al, 2008) . Our finding does not preclude the possibility that other caspase pathways are triggered 
